Screening Platform for Retrospective Chemical Exposure Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively detect past exposure to chemical agents or heavy metals, as these substances are often flushed from the body quickly, leaving no trace, and existing technologies lack the ability to identify specific biomarkers for small or chronic exposures, limiting the ability to diagnose and track exposure-related health effects.
Innovation Solution
A screening platform using a capture material coated with a reagent that binds to target antibodies associated with chemical agents or heavy metals, allowing for the determination of past exposure by interrogating clinical samples, employing phage or DNA libraries to generate indicators of protein adducts or modifications that can be detected through immunoassay techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional detection methods are used to detect chemical agents or heavy metals, then detection can be performed, but the ability to detect past exposure is lost because these substances are flushed from the body quickly
Solution Approach 1:
The patent uses host proteins as intermediary carriers that bind to chemical agents or heavy metals to form stable protein adducts. These adducts serve as persistent biomarkers that remain in the body long after the original chemical agent has been eliminated, enabling retrospective exposure detection through antibody assays against the adducts
Solution Approach 2:
The method performs preliminary binding of chemical agents to host proteins at the moment of exposure, creating stable adducts before the chemical agent can be eliminated. This preliminary action ensures that evidence of exposure is captured and preserved in the form of protein adducts that can be detected later
2Measurement precision
If conventional methods are used to detect chemical exposures, then some exposures can be detected, but the ability to identify specific biomarkers for small or chronic exposures is lacking
Solution Approach 1:
The patent segments the complex problem of chemical exposure detection into specific protein adduct identification. By focusing on individual host proteins that become modified by chemical agents, the method creates discrete, detectable biomarkers that provide precise information about specific exposures rather than general presence/absence data
Solution Approach 2:
The method employs immunoassay techniques that produce detectable signals (analogous to color changes) when antibodies bind to protein adducts. This enables sensitive detection of specific exposure biomarkers through optical or other signal transduction methods that amplify the presence of trace adducts
3Adaptability or versatility
If comprehensive screening for multiple chemical exposures is performed, then exposure identification capability improves, but the complexity of the detection system increases
Solution Approach 1:
The patent employs a universal host proteome that can bind to multiple different chemical agents and heavy metals. The same basic assay platform and antibody detection methodology can be applied to detect various different exposures by analyzing which specific host proteins are modified, providing multi-chemical detection capability without requiring separate complex systems for each agent
Solution Approach 2:
The method creates a comprehensive library of host proteins that serve as templates for all possible chemical interactions. By having pre-characterized host proteome data and using standardized antibody assays, the system can screen for multiple chemicals using a replicated, scalable platform rather than requiring unique complex instrumentation for each analyte
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the detection of past exposure to multiple chemicals or heavy metals, providing a timeline of exposure events and aiding in the diagnosis of health effects, and can be used for both public health monitoring and intelligence-related incidents, enhancing the capability to intervene in exposure-related incidents.
Implementation Method 1
a capture reagent. The capture reagent may be selected based on an ability of the capture reagent to bind with a target antibody, and the target antibody may be an indicator associated with a particular chemical agent or heavy metal
Implementation Method 2
determining an exposure status of the individual to the particular chemical agent or heavy metal based on whether the capture material demonstrates capture of the indicator
Data Source
AI summary
A method for determining past exposure to chemical agents or heavy metals may include coating a capture material with a capture reagent. The capture reagent may be selected based on an ability of the capture reagent to bind with a target antibody, and the target antibody may be an indicator associated with a particular chemical agent or heavy metal. The method may further include interrogating a clinical sample associated with an individual by forming a mixture of the capture material and the clinical sample, and determining an exposure status of the individual to the particular chemical agent or heavy metal based on whether the capture material demonstrates capture of the indicator.